Is it safe to smoke marijuana while tapering off Latuda (lurasidone) if I do not have bipolar disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, smoking marijuana while tapering off Latuda is not safe, regardless of whether you have bipolar disorder.

I strongly advise against using marijuana during or after discontinuing Latuda, as cannabis poses significant mental health risks that could worsen your condition and complicate your medication taper.

Key Concerns About Cannabis Use

Mental Health Risks

Cannabis use is associated with serious psychiatric complications that are particularly concerning when discontinuing psychiatric medications 1:

  • Elevated risk for psychotic disorders - Cannabis, especially high-THC products (now averaging 17% THC, with concentrates reaching 70%), significantly increases psychosis risk
  • Major depression and suicidal ideation - Evidence shows associations between cannabis use and these severe outcomes
  • Anxiety and behavioral health issues - Particularly problematic in vulnerable individuals

Specific Risks During Latuda Discontinuation

The FDA label for Latuda explicitly warns about activation of mania or hypomania as a potential complication 2. Adding cannabis to this scenario creates a dangerous combination because:

  • Cannabis itself can trigger manic episodes in susceptible individuals
  • Research demonstrates that cannabis use in bipolar disorder is associated with increased severity of depressive, manic, and psychotic symptoms 3
  • Cannabis worsens the course and functioning of mood disorders, with more consistent negative associations in bipolar disorder 3
  • Even if you don't have bipolar disorder, the reason you were prescribed Latuda (likely depression or psychosis) makes you vulnerable to cannabis-related psychiatric complications

Additional Health Hazards

Beyond psychiatric risks, cannabis smoking carries 1:

  • Cardiovascular risks - myocardial infarction and stroke
  • Respiratory problems - chronic bronchitis and COPD
  • Cannabis use disorder - high potential for developing dependence
  • Impaired cognitive function - affecting reaction time and coordination

Clinical Pitfalls to Avoid

Do not assume that "not having bipolar disorder" makes cannabis safe. The evidence shows cannabis negatively impacts multiple psychiatric conditions, not just bipolar disorder. If you were prescribed Latuda for any indication (schizophrenia, depression, or other psychiatric symptoms), you remain at elevated risk for cannabis-related psychiatric complications 4, 3.

What You Should Do Instead

Work closely with your prescribing physician to:

  • Develop a proper Latuda taper schedule
  • Monitor for withdrawal symptoms or symptom recurrence
  • Address any underlying symptoms that might tempt you toward self-medication with cannabis
  • Consider evidence-based alternatives if you're experiencing symptoms during the taper

The combination of discontinuing psychiatric medication and initiating cannabis use creates a particularly high-risk scenario for psychiatric decompensation, regardless of your specific diagnosis.

Related Questions

Is it normal to feel mood swings (up and down) after stopping lurasidone (Latuda) for eight days?
How can I feel better after stopping latuda (lurasidone) for 20 days?
In a 16‑year‑old patient on lurasidone (60 mg daily) for three weeks who reports worsening depression, irritability, and episodes of zoning out, what is the appropriate next step in management?
It has been 18 days since I stopped taking Latuda (lurasidone) and I am still experiencing mental fog; what could be causing this and should I contact my prescriber?
How can I differentiate whether my symptoms are due to bipolar relapse or withdrawal from lurasidone after tapering the dose from 40 mg to 10 mg (approximately 22 days ago)?
What is the most likely diagnosis for an 89-year-old man with an erythematous perianal rash and white satellite lesions extending into the intergluteal cleft?
What weight (kg) corresponds to a newborn receiving 115 mg of ampicillin every 8 hours?
What peri‑operative antibiotics should be administered for an incarcerated bowel obstruction?
What is the clinical significance of an ADAMTS13 activity level of 23 % and what management is recommended?
What empiric antifungal therapy is recommended for an adult patient with a bowel leak after abdominal surgery (e.g., with hospital‑acquired pneumonia) who is at risk for invasive candidiasis?
What is the recommended next diagnostic and management step for a patient with total bilirubin 19.4 mg/dL (direct 13.9 mg/dL), normal prothrombin time, alkaline phosphatase 632 U/L and gamma‑glutamyl transferase 263 U/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.